The European dental biomaterial market will grow moderately through 2027, driven by an increasing number of GDs offering dental implant therapy and widespread awareness of dental implant treatments, leading to a greater volume of procedures incorporating dental biomaterials because bone grafting is often performed alongside dental implant placements. Companies in this space are also investing in innovative technologies to expand revenues and gain shares in this market.
This Medtech 360 Report provides high-level market metrics for biosurgical agents in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Dental Biomaterials - Market Insights - Europe (Supplemental)
Author(s): Meenu Sankar, MS
Meenu Sankar is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde.
Follow Meenu on Twitter:@meenu_sankarDRG